Multimodal Deep Learning with Routine Clinical Data for Recurrence Risk Stratification in HR&lt;sup&gt;+&lt;/sup&gt;/HER2&lt;sup&gt;-&lt;/sup&gt; Early Breast Cancer. This evidence concerns the gene ERBB2 and breast cancer.